Genmab A/S Adjustments For Finance Costs
Genmab A/S (GMAB) reported Adjustments For Finance Costs of $269.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForFinanceCosts · last filed 2026-02-17
DKK
| Period end | Adjustments For Finance Costs 6 month | Adjustments For Finance Costs 12 month |
|---|---|---|
| 2024-12-31 | 1.98B DKK 6-K · filed 2025-02-12 | |
| 2024-06-30 | 591.00M DKK 6-K · filed 2024-08-08 | |
| 2023-12-31 | 1.62B DKK 6-K · filed 2025-02-12 | |
| 2023-06-30 | 663.00M DKK 6-K · filed 2024-08-08 | |
| 2022-12-31 | 2.51B DKK 6-K · filed 2025-02-12 |
USD
| Period end | Adjustments For Finance Costs 6 month | Adjustments For Finance Costs 12 month |
|---|---|---|
| 2025-12-31 | $269.00M 20-F · filed 2026-02-17 | |
| 2025-06-30 | $134.00M 6-K · filed 2025-08-07 | |
| 2024-12-31 | $291.00M 20-F · filed 2026-02-17 | |
| 2024-06-30 | $80.00M 6-K · filed 2025-08-07 | |
| 2023-12-31 | $254.00M 20-F · filed 2026-02-17 |